Published in Calif Med on December 01, 1967
Uveitis survey sponsored by the American Academy of Ophthalmology and Otolaryngology. Am J Ophthalmol (1961) 1.39
Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein. J Exp Med (1973) 3.15
Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science (1994) 1.99
Serologic tests for syphilis and the false-positive reactor. Arch Dermatol (1966) 1.95
Fluorescent treponemal-antibody absorption tests. Studies of false-positive reactions to tests for syphilis. N Engl J Med (1967) 1.91
The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor). J Exp Med (1971) 1.65
Plasma prekallikrein: isolation, characterization, and mechanism of activation. J Exp Med (1972) 1.62
Prekallikrein deficiency in man. J Exp Med (1973) 1.53
Flaujeac trait. Deficiency of human plasma kininogen. J Clin Invest (1975) 1.49
Activation of the alternative (properdin) pathway of complement by Candida albicans and related species. J Invest Dermatol (1976) 1.45
Photocontact dermatitis to halogenated salicylanilides and related compounds. A clinical and histological review of 26 patients. Arch Dermatol (1968) 1.41
Cutaneous responses to human C 3 anaphylatoxin in man. Clin Exp Immunol (1972) 1.39
Experimental cutaneous candidiasis in rodents. J Invest Dermatol (1976) 1.15
Effect of plasma kallikrein on coagulation in vitro. Proc Soc Exp Biol Med (1972) 1.15
Keratolinin: the soluble substrate of epidermal transglutaminase from human and bovine tissue. Proc Natl Acad Sci U S A (1984) 1.13
Isolation and purification of a pemphigus vulgaris antigen from human epidermis. J Clin Invest (1984) 1.07
Erythropoietic protoporphyria. A clinical and genetic study. JAMA (1970) 1.05
The interaction of Hageman factor and immune complexes. J Clin Invest (1972) 1.04
Isolation, purification and characterization of bovine epidermal transglutaminase. Biochim Biophys Acta (1976) 1.03
Experimental cutaneous candidiasis in rodents; II. Role of the stratum corneum barrier and serum complement as a mediator of a protective infalmmatory response. Arch Dermatol (1978) 1.01
Cushing's syndrome with adrenal medullary insufficiency and adrenal autoantibodies. Lancet (1966) 0.99
Erythema multiforme: immune complex vasculitis of the superficial cutaneous microvasculature. J Invest Dermatol (1978) 0.99
Purification of a mannan from Candida albicans which activates serum complement. J Invest Dermatol (1979) 0.98
Purification and characterization of a staphylococcal epidermolytic toxin. Infect Immun (1976) 0.98
Cutaneous extramedullary plasmacytomas. Arch Dermatol (1969) 0.97
Cellular localization of epidermal transglutaminase: a histochemical and immunochemical study. J Histochem Cytochem (1978) 0.96
Immune complexes in erythema multiforme and the Stevens-Johnson syndrome. J Invest Dermatol (1980) 0.95
Epidermal transglutaminase. Identification and purification of a soluble substrate with studies of in vitro cross-linking. J Biol Chem (1980) 0.94
Epidermal and hair follicle transglutaminases and crosslinking in skin. Mol Cell Biochem (1984) 0.93
Measurement of the staphylococcal epidermolytic toxin: a comparison of bioassay, radial immunodiffusion, and radioimmunoassay. J Invest Dermatol (1976) 0.93
Toxic epidermal necrolysis. Unmuddying the waters. Arch Dermatol (1987) 0.90
Biochemistry of transglutaminases and cross-linking in the skin. J Invest Dermatol (1983) 0.90
Moniliasis, 'autoimmune' polyendocrinopathy, and immunologic family study. Clin Exp Immunol (1967) 0.89
Staphylococcal scalded skin syndrome: detection of antibody to epidermolytic toxin by a primary binding assay. Clin Exp Dermatol (1978) 0.89
Diet-induced systemic lupus erythematosus (SLE) in primates. Am J Kidney Dis (1982) 0.87
Rapid renal failure in a case of multiple myeloma: the role of Bence Jones proteins. Clin Exp Immunol (1968) 0.87
The epidermolytic toxin of Staphylococcus aureus: its failure to bind to cells and its detection in blister fluids of patients with bullous impetigo. J Invest Dermatol (1978) 0.86
Herpes simplex antigen in immune complexes of patients with erythema multiforme: presence following recurrent herpes simplex infection. JAMA (1982) 0.86
Studies of the mechanism of epidermal injury by a Staphylococcal epidermolytic toxin. J Invest Dermatol (1975) 0.85
Immunologic aspects of adrenocortical insufficiency. Am J Med (1969) 0.85
Purification of human epidermal calmodulin. J Invest Dermatol (1983) 0.84
Paraben contact dermatitis. JAMA (1967) 0.84
Erythema multiforme: clinical spectrum and immunopathogenesis. Springer Semin Immunopathol (1981) 0.83
Isolation and partial characterization of a keratinocyte proliferative factor produced by Streptococcus pyogenes (strain NY-5). J Invest Dermatol (1978) 0.83
Human mononuclear leukocyte transglutaminase activity is enhanced by streptococcal erythrogenic toxin and a staphylococcal mitogenic factor associated with toxic shock syndrome. Biochim Biophys Acta (1984) 0.83
An appraisal of the operative and nonoperative treatment of sigmoid volvulus. Surg Gynecol Obstet (1966) 0.81
Keratin cross-linking and epidermal transglutaminase. A review with observations on the histochemical and immunochemical localization of the enzyme. J Invest Dermatol (1975) 0.81
On the presence of gamma G and beta-1 C globulins in renal glomeruli of aging and neonatally x-irradiated mice. Vox Sang (1967) 0.81
Soluble mediators of injury of the microvasculature; Hageman factor and the kinin forming, intrinsic clotting and the fibrinolytic systems. Microvasc Res (1974) 0.79
Cloning of human keratolinin cDNA: keratolinin is identical with a cysteine proteinase inhibitor, cystatin A, and is regulated by Ca2+, TPA, and cAMP. J Invest Dermatol (1997) 0.78
Purification and characterization of streptococcal proliferative factor. J Invest Dermatol (1981) 0.77
Immunoregulation in atopic dermatitis: functional analysis of T-B cell interactions and the enumeration of Fc receptor-bearing T cells. J Invest Dermatol (1983) 0.77
Dermatitis herpetiformis: effects of sulfones and sulfonamides on neutrophil myeloperoxidase-mediated iodination and cytotoxicity. J Clin Immunol (1984) 0.77
Repeat direct immunofluorescence to discriminate pemphigoid from epidermolysis bullosa acquisita. Arch Dermatol (1990) 0.75
Inherited deficiencies of complement in man. Int J Dermatol (1977) 0.75
Effect of nalorphine and levallorphan on brain concentrations of levorphanol in the dog. Proc Soc Exp Biol Med (1967) 0.75
Erythema multiforme. Clin Rheum Dis (1982) 0.75
[Staphylogenous Lyell's syndrome]. Hautarzt (1977) 0.75
Mucous membrane pemphigoid-immunofluorescent studies. J Dent Res (1970) 0.75
Recent advances in cutaneous candidiasis. Int J Dermatol (1978) 0.75
Proceedings: Flaujeac trait: deficiency of human HMW kininogen. Thromb Diath Haemorrh (1975) 0.75
Occult nontropical sprue and associated atrophic gastritis simulating Addisonian pernicious anemia, with special reference to immunologic diagnostic studies. Acta Med Scand Suppl (1966) 0.75
Circulating factor IX antigen-inhibitor complexes in hemophilia B- following infusion of a factor IX concentrate. Blood (1979) 0.75
Clinical and physiologic studies of two siblings with prekallikrein (Fletcher factor) deficiency. Am J Med (1976) 0.75
Erythrocyte fluorescence in relatives of patients with erythropoietic protoporphyria. JAMA (1967) 0.75
The role of divalent cations in epidermolysis. Br J Dermatol (1976) 0.75